If there’s a widely held – but false – belief about Social Security, it is that the monthly check (the average amount is $1,341, and the maximum amount is about $3,576) is tax free. Don’t tell that to the 40% of beneficiaries who pay federal income tax on the check. There’s even a special IRS publication....More>>>
Our Top Pick for more speculative investors is a biopharmaceutical company that discovers, develops, and commercializes oral antivirals in areas of unmet medical needs in the United States, explains Bill Mathews, editor of The Cheap Investor.
The lead product candidate from Chimerix (CMRX) is brincidofovir (CMX001), a nucleotide analog.
The drug is in Phase III clinical trials....More>>>
President Trump’s executive order rolling back energy regulations is unlikely to spawn a surge of jobs or a quick reduction offuel prices, as the basic rules of economics maintain a powerful hold on the industry.
Will coal jobs suddenly come roaring back? Dont bet on it. Will the price of electricity go into reverse? Not likely. Will increased federal land rights for oil and natural....More>>>
Judging by some of the best-known retail stocks, youd think Americas shopping malls were ghost towns. Shares of Macys (M, $31.31) trade for 57% less than the price they commanded last July. Nordstrom (JWN, $36.68) has plunged by 55% since March 2015. And Kohls (KSS, $34.49) has sunk 56% since April 2015. Over the past year through June 14, SPDR S&P Retail ETF (XRT, $41.10), an exchange-traded....More>>>
Organovo Holdings Inc. (NASDAQ: ONVO) shares saw a handy gain on Tuesday after the bio-printer announced that it received a strong consumer response from its second tissue service. Specifically, the ExVive Human Kidney Tissue launched in September, which uses Organovos 3D bio-printed kidney tissue to study the effects of drug exposure through toxicology panels and transporter studies.
Beating Alzheimers is going to be a team sport. We now have our new quarterback. Referencing billionaire Microsoft co-founder Bill Gates announcement today to join the fight to cure Alzheimers, George Vradenburg, chairman, president and co-founder of UsAgainstAlzheimers - a movement bent on stop
Sales Trends A Bit Soft, But Nothing To Worry About
I have been a bit disappointed by Nordstroms (NYSE:JWN) recent results. Not because it was a bad quarter per se, but because it broke the sequence of constant overperformance compared to other peers in the
It's been a bad month for Pegasystems (NASDAQ: PEGA), with investors running for the exits after a huge top-line miss in Q3. For an enterprise software company, there's probably nothing worse. Pegasystems sold off from all-time highs near $65 and now trades nearly 20% lower, in the low $50s.
I have previously written some articles where I have tracked Tesla's (NASDAQ:TSLA) construction and purchases of property, plant, and equipment (P,P & E), as well as Tesla's payments for them. The reason Tesla does not have to pay for all its equipment up front was explained in